Immunogenicity and safety of different schedules of 2-dose varicella vaccination in China

References

• Papaloukas O, Giannouli G, Papaevangelou V. Successes and challenges in varicella vaccine. Ther Adv Vaccines 2014; 2(2):39-55; PMID:24757524; http://dx.doi.org/10.1177/2051013613515621
   PubMedGoogle Scholar
• Committee on Infectious Diseases. Prevention of varicella: Recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule. Pediatrics 2007; 120(1):221-31; PMID:17606582; http://dx.doi.org/10.1542/peds.2007-1089
   PubMed Web of Science ®Google Scholar
• Xu Q, Xu AQ. Epidemiological analysis of varicella in China and advance in immunity prevention for varicella vaccine. Chinese J New Drugs 2012; 21(10):1093-8
   Google Scholar
• China Information System for Disease Control and Prevention.
   Google Scholar
• Li L, Suo LD, Li J, Zhai LJ, Zheng QX, Pang XH. A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China. Vaccine 2012; 30(34):5094-8; PMID:22687763; http://dx.doi.org/10.1016/j.vaccine.2012.05.072
   PubMed Web of Science ®Google Scholar
• Zhang X, Yu YC, Zhang J, Huang ST, Wang ZZ, Zhang JJ, Yan Y, Liu F, Zhao J, He Y. The epidemiology of varicella cases among children in Beijing's Fengtai District from 2008 to 2012. Vaccine 2014; 32(29):3569-72; PMID:24791731; http://dx.doi.org/10.1016/j.vaccine.2014.04.069
   PubMed Web of Science ®Google Scholar
• Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG. The safety profile of varicella vaccine: A 10-year review. J Infect Dis 2008; 197(Suppl 2):S165-9; PMID:18419392; http://dx.doi.org/10.1086/522125
   PubMed Web of Science ®Google Scholar
• Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, Stefkovičova M, Usonis V, Wysocki J, Douha M, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicenter, observer-blind, randomized, controlled trial. Lancet 2014; 383(9925):1313-24; PMID:24485548; http://dx.doi.org/10.1016/S0140-6736(12)61461-5
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang H, Li K, Zhang A, Feng Z, Seward JF, Bialek SR, Wang C. Single-dose varicella vaccine effectiveness in school settings in China. Vaccine 2014; 31(37):3834-8; http://dx.doi.org/10.1016/j.vaccine.2013.06.075
   Web of Science ®Google Scholar
• Mahamud A, Wiseman R, Grytdal S, Basham C, Asghar J, Dang T, Leung J, Lopez A, Schmid DS, Bialek SR. Challenges in confirming a varicella outbreak in the two-dose vaccine era. Vaccine 2012; 30(48):6935-9; PMID:22884663; http://dx.doi.org/10.1016/j.vaccine.2012.07.076
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Vazquez M, Esposito D, Holabird N, Steinberg SP, Dziura J, LaRussa PS, Gershon AA. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis 2011; 203(3):312-5; PMID:21208922; http://dx.doi.org/10.1093/infdis/jiq052
   PubMed Web of Science ®Google Scholar
• Sheffer R, Segal D, Rahamani S, Dalal I, Linhart Y, Stein M, Shohat T, Somekh E. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J 2005; 24(5):434-7; PMID:15876943; http://dx.doi.org/10.1097/01.inf.0000160947.89942.30
   PubMed Web of Science ®Google Scholar
• Cenoz MG, Martínez-Artola V, Guevara M, Ezpeleta C, Barricarte A, Castilla J. Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain. Hum Vaccin Immunother 2013; 9(5):1172-6; PMID:23324571; http://dx.doi.org/10.4161/hv.23451
   PubMed Web of Science ®Google Scholar
• Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 2004; 24(2):132-7; http://dx.doi.org/10.1097/01.inf.0000109287.97518.67
   Web of Science ®Google Scholar
• Watson B, Rothstein E, Bernstein H, Arbeter A, Arvin A, Chartrand S, Clements D, Kumar ML, Reisinger K, Blatter M, et al. Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization. J Infect Dis 1995; 172(1):217-9; PMID:7797914; http://dx.doi.org/10.1093/infdis/172.1.217
   PubMed Web of Science ®Google Scholar
• Ngai AL, Staehle BO, Kuter BJ, Cyanovich NM, Cho I, Matthews H, Keller P, Arvin AM, Watson B, White CJ. Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children. Pediatr Infect Dis J 1996; 15:49-54; PMID:8684876; http://dx.doi.org/10.1097/00006454-199601000-00011
   PubMed Web of Science ®Google Scholar
• Kawai K, O'Brien MA, Conway JH, Marshall GS, Kuter BJ. Factors associated with receipt of two doses of varicella vaccine among adolescents in the United States. Pediatr Infect Dis J 2013; 32(5):538-42; PMID:23190788; http://dx.doi.org/10.1097/INF.0b013e31827f4c3c
   PubMed Web of Science ®Google Scholar
• Daly ER, Anderson L, Dreisig J, Dionne-Odom J. Decrease in varicella incidence after implementation of the 2-dose recommendation for varicella vaccine in New Hampshire. Pediatr Infect Dis J 2013; 32(9):981-3; PMID:23538516; http://dx.doi.org/10.1097/INF.0b013e318293308e
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, AbuKhamsin A, Memish ZA. Epidemiology and impact of varicella vaccination: A longitudinal study 1994-2011. Travel Med Infect Dis 2013; 11(5):310-4; PMID:23810308; http://dx.doi.org/10.1016/j.tmaid.2013.06.002
   PubMed Web of Science ®Google Scholar
• Bialek SR, Perella D, Zhang J, Mascola L, Viner K, Jackson C, Lopez AS, Watson B, Civen R. Impact of a routine two-dose varicella vaccination program on varicella epidemiology. Pediatrics 2013; 132(5):e1134-40; PMID:24101763; http://dx.doi.org/10.1542/peds.2013-0863
   PubMed Web of Science ®Google Scholar
• Zhang J, Delzell E, Xie F, Baddley JW, Spettell C, McMahan RM, Fernandes J, Chen L, Winthrop K, Curtis JR. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study. Arthritis Res Ther 2011; 13(5):R174-83; PMID:22024532; http://dx.doi.org/10.1186/ar3497
   PubMed Web of Science ®Google Scholar
• Thomas CA, Shwe T, Bixler D, del Rosario M, Grytdal S, Wang C, Haddy LE, Bialek SR. Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students. Pediatr Infect Dis J 2014; 33(11):1164-8; PMID:24911894; http://dx.doi.org/10.1097/INF.0000000000000444
   PubMed Web of Science ®Google Scholar
• Lopez AS, Cardemil C, Pabst LJ, Cullen KA, Leung J, Bialek SR. Two-dose varicella vaccination coverage among children aged 7 years - six sentinel sites, United States, 2006-2012. MMWR Morb Mortal Wkly Rep 2014; 63(8):174-7; PMID:24572613
   PubMed Web of Science ®Google Scholar
• Zhou F, Ortega-Sanchez IR, Guris D, Shefer A, Lieu T, Seward JF. An economic analysis of the universal varicella vaccination program in the United States. J Infect Dis 2008; 197(Suppl 2):S156-64; PMID:18419391; http://dx.doi.org/10.1086/522135
   PubMedGoogle Scholar
• Hammerschmidt T¸, Bisanz H, Wutzler P. Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis. Vaccine 2007; 25(42):7037-12; http://dx.doi.org/10.1016/j.vaccine.2007.08.017
   Web of Science ®Google Scholar
• Macartney K. Prevention of varicella: time for two-dose vaccination. Lancet 2014; 383(9925):1276-7; PMID:24485547; http://dx.doi.org/10.1016/S0140-6736(14)60078-7
   PubMed Web of Science ®Google Scholar
• Bonanni P, Gershon A, Gershon M, Kulcsár A, Papaevangelou V, Rentier B, Sadzot-Delvaux C, Usonis V, Vesikari T, Weil-Olivier C, et al. Primary versus secondary failure after varicella vaccination: Implications for interval between 2 doses. Pediatr Infect Dis J 2013; 32(7):e305-13; PMID:23838789; http://dx.doi.org/10.1097/INF.0b013e31828b7def
   PubMed Web of Science ®Google Scholar
• Marin M, Watson TL, Chaves SS, Civen R, Watson BM, Zhang JX, Perella D, Mascola L, Seward JF. Varicella among adults: data from an active surveillance project, 1995-2005. J Infect Dis 2008; 197(Suppl 2):S94-100; PMID:18419417; http://dx.doi.org/10.1086/522155
   PubMedGoogle Scholar
• Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec 2014; 89(25):265-87; PMID:24983077
   PubMedGoogle Scholar
• He HH, Chen EF, Chen HP, Wang ZF, Li Q, Yan R, Guo J, Zhou Y, Pan J, Xie S. Similar immunogenicity of measles–mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children. Vaccine 2014; 32(31):4001-5; PMID:24837773; http://dx.doi.org/10.1016/j.vaccine.2014.04.044
   PubMed Web of Science ®Google Scholar